Search
for
Sort by
Research 121–150 of 1000+
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- PRIDE syndrome with lumbosacral hypertrichosis
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- 785 Single-cell transcriptomic profile of EGFR-deficient epidermal compartments during folliculitis
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic Reactions to Targeted Therapy
- Management of Toxicities of Targeted Therapies
- Sorafenib-induced Facial Acneiform Eruption
- KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild‐type and BK5.Akt<sup>WT</sup> mice
- An overview of management of drug-induced hair and nail disorders
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammation and collagen deposition
- Dermatologic Adverse Events from Cancer Treatments
- Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid
- Cutaneous Side Effects of Chemotherapy and Radiotherapy